RYTM

NASDAQStock

Rhythm Pharmaceuticals, Inc.

$92.61+2.52 (+2.80%)

52-Week Range

$46.95
$117.62

Key Stats

Market Cap

6.3B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.15

Volume

396.9K

Avg Volume

834.5K

Performance

1M

-11.39%

3M

-19.73%

6M

-5.08%

YTD

-13.20%

1Y

+77.61%

3Y

+376.98%

5Y

+245.00%

Price Chart

ETF Exposure

RYTM is held by 94 ETFs

ETFFund NameWeight
VBVanguard Small-Cap ETF0.09%
VHTVanguard Health Care ETF0.09%
ISCBiShares Morningstar Small-Cap ETF0.09%
JKJiShares Morningstar Small-Cap ETF0.09%
GSSCGoldman Sachs ActiveBeta U.S. Small Cap Equity ETF0.08%
FHLCFIDELITY MSCI HEALTH CARE INDEX ETF0.08%
TNXTT. Rowe Price Innovation Leaders ETF0.08%
VXFVanguard Extended Market ETF0.08%
ESMLiShares ESG Aware MSCI USA Small-Cap ETF0.07%
PRFZInvesco RAFI US 1500 Small-Mid ETF0.06%
WSMLiShares MSCI World Small-Cap ETF0.05%
OMFSInvesco Russell 2000 Dynamic Multifactor ETF0.05%
PTLInspire 500 ETF0.04%
JHMMJohn Hancock Investments - Multifactor Mid Cap ETF0.04%
SMMDiShares Russell 2500 ETF0.04%
HDGProShares - Hedge Replication ETF0.02%
SPGMState Street SPDR Portfolio MSCI Global Stock Market ETF0.02%
ONEQFIDELITY NASDAQ COMPOSITE INDEX ETF0.02%
TILTFlexShares Morningstar U.S. Market Factor Tilt Index Fund0.01%
VTIVanguard Total Stock Market ETF0.01%
ITOTiShares Core S&P Total U.S. Stock Market ETF0.01%
SCHBSchwab U.S. Broad Market ETF0.01%
SCHKSchwab 1000 Index ETF0.01%
VTHRVanguard Russell 3000 ETF0.01%
IWViShares Russell 3000 ETF0.01%
IALTiShares Systematic Alternatives Active ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
EAOAiShares ESG Aware 80/20 Aggressive Allocation ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
EAOKiShares ESG Aware 30/70 Conservative Allocation ETF0.00%
EAOMiShares ESG Aware 40/60 Moderate Allocation ETF0.00%
EAORiShares ESG Aware 60/40 Balanced Allocation ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
LSLTPacer Salt Low truBeta US Market ETF0.00%
SLTPacer Salt High truBeta US Market ETF0.00%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF0.00%
VETSPacer Military Times Best Employers ETF0.00%
VIRSPacer BioThreat Strategy ETF0.00%
PreviousPage 2 of 2

About RYTM ETF Exposure

Rhythm Pharmaceuticals, Inc. (RYTM) is held by 94 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 6.3B, RYTM is a widely held institutional stock. The stock currently trades at $92.61. Investors can gain exposure to RYTM through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold RYTM, sorted by portfolio weight.